Nicholas Company, Inc. Johnson & Johnson Transaction History

Nicholas Company, Inc.

$5.86 Billion
Q3 2024

A detailed history of Nicholas Company, Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, Nicholas Company, Inc. holds 49,615 shares of JNJ stock, worth $7.72 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

49,615

Previous 49,615 -0.0%

Holding current value

$7.72 Million

Previous $7.25 Million 10.88%

% of portfolio

0.14%

Previous 0.12%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$145.6 - $158.88 $40 Million - $43.6 Million	-274,695 Reduced 84.7%	49,615 $7.78 Million
Q3 2023 Feb 13, 2024	SELL	$155.75 - $174.48 $966,428 - $1.08 Million	-6,205 Reduced 1.88%	324,310 $50.5 Million
Q3 2023 Nov 13, 2023	SELL	$155.75 - $174.48 $966,428 - $1.08 Million	-6,205 Reduced 1.88%	324,310 $50.5 Million
Q1 2023 Feb 13, 2024	BUY	$151.05 - $180.26 $6.31 Million - $7.53 Million	41,765 Added 14.46%	330,515 $51.2 Million
Q1 2023 May 11, 2023	BUY	$151.05 - $180.26 $6.31 Million - $7.53 Million	41,765 Added 14.46%	330,515 $51.2 Million
Q4 2022 Feb 13, 2024	SELL	$160.2 - $179.79 $11,214 - $12,585	-70 Reduced 0.02%	288,750 $51 Million
Q4 2022 Feb 09, 2023	SELL	$160.2 - $179.79 $11,214 - $12,585	-70 Reduced 0.02%	288,750 $51 Million
Q3 2022 Feb 13, 2024	SELL	$161.33 - $179.52 $1,613 - $1,795	-10 Reduced -0.0%	288,820 $47.2 Million
Q3 2022 Nov 14, 2022	SELL	$161.33 - $179.52 $1,613 - $1,795	-10 Reduced -0.0%	288,820 $47.2 Million
Q2 2022 Feb 13, 2024	SELL	$168.19 - $186.01 $8.14 Million - $9 Million	-48,400 Reduced 14.35%	288,830 $51.3 Million
Q2 2022 Jul 26, 2022	SELL	$168.19 - $186.01 $8.14 Million - $9 Million	-48,400 Reduced 14.35%	288,830 $51.3 Million
Q1 2022 Feb 13, 2024	BUY	$158.14 - $179.59 $2.04 Million - $2.32 Million	12,920 Added 3.98%	337,230 $59.8 Million
Q1 2022 May 11, 2022	SELL	$158.14 - $179.59 $11,860 - $13,469	-75 Reduced 0.02%	337,230 $59.8 Million
Q4 2021 Feb 11, 2022	SELL	$155.93 - $173.01 $3,898 - $4,325	-25 Reduced 0.01%	337,305 $57.7 Million
Q3 2021 Nov 15, 2021	SELL	$161.5 - $179.47 $312,502 - $347,274	-1,935 Reduced 0.57%	337,330 $54.5 Million
Q1 2021 May 14, 2021	SELL	$153.07 - $170.48 $198,991 - $221,624	-1,300 Reduced 0.38%	339,265 $55.8 Million
Q4 2020 Feb 10, 2021	SELL	$137.11 - $157.38 $1.25 Million - $1.44 Million	-9,150 Reduced 2.62%	340,565 $53.6 Million
Q3 2020 Nov 13, 2020	BUY	$140.38 - $153.83 $464,657 - $509,177	3,310 Added 0.96%	349,715 $52.1 Million
Q2 2020 Aug 13, 2020	SELL	$128.81 - $155.51 $1.61 Million - $1.94 Million	-12,500 Reduced 3.48%	346,405 $48.7 Million
Q1 2020 May 13, 2020	SELL	$111.14 - $153.99 $416,775 - $577,462	-3,750 Reduced 1.03%	358,905 $47.1 Million
Q4 2019 Feb 13, 2020	BUY	$127.5 - $146.44 $3,187 - $3,661	25 Added 0.01%	362,655 $52.9 Million
Q3 2019 Nov 14, 2019	BUY	$126.95 - $142.14 $2.55 Million - $2.85 Million	20,060 Added 5.86%	362,630 $46.9 Million
Q2 2019 Aug 13, 2019	BUY	$131.15 - $144.24 $24,918 - $27,405	190 Added 0.06%	342,570 $47.7 Million
Q1 2019 May 14, 2019	SELL	$125.72 - $139.79 $374,645 - $416,574	-2,980 Reduced 0.86%	342,380 $47.9 Million
Q4 2018 Feb 14, 2019	BUY	$122.84 - $147.84 $4.17 Million - $5.02 Million	33,985 Added 10.91%	345,360 $44.6 Million
Q3 2018 Nov 14, 2018	BUY	$121.58 - $142.88 $4.53 Million - $5.33 Million	37,290 Added 13.61%	311,375 $43 Million
Q2 2018 Aug 14, 2018	BUY	$119.4 - $131.76 $5.28 Million - $5.83 Million	44,250 Added 19.25%	274,085 $33.3 Million
Q1 2018 May 14, 2018	BUY	$125.1 - $148.14 $3.83 Million - $4.54 Million	30,635 Added 15.38%	229,835 $29.5 Million
Q4 2017 Feb 14, 2018	BUY	$131.22 - $143.62 $26.1 Million - $28.6 Million	199,200	199,200 $27.8 Million

Others Institutions Holding JNJ

# of Institutions

4,271

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $407B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nicholas Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Nicholas Company, Inc. with notifications on news.

Account

Nicholas Company, Inc. Johnson & Johnson Transaction History